More States Vote on Cannabis Legalization

Monday, November 7, 2016 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, November 7, 2016 /PRNewswire/ --

Cannabis legalization is a big deal this election year. According to ArcView

Market Research which was reported by and New Frontier, the value of the legal marijuana industry is expected to reach $7 billion by the end of this year, assuming only California votes in
favor of legalization. In comparison, the value of legal marijuana industry in 2015 just went over $1 billion, and was only about $351 million in 2014. Canadian Zeolite Corp. (OTC: CNZCF), General Cannabis Corp. (OTC: CANN), American Cannabis Company Inc. (OTC: AMMJ), Terra Tech Corp. (OTC: TRTC), GrowBlox Sciences Inc. (OTC: GBLX)

Legalization measures are on Ballots in nine states, and if all the measures pass, it will mean that nearly a quarter of Americans will be able to use cannabis for both medical and recreational purposes. Five of the nine states - California, Nevada, Arizona, Massachusetts and Maine will be voting specifically on legalization of cannabis recreationally.

Canadian Zeolite Corp. (OTCQB: CNZCF) is an environmentally friendly Green Tech business well suited to today's economic environment. The company explains the value of Zeolite, which is a naturally occurring mineral found in volcanic ash, and is unique notable in its crystalline structure perforated by microscopic pores. These pores allow zeolites to act as natural filters. As a result, Zeolites (microporous) are used across several industries for a variety of purposes, including water purification and radioactive waste containment.

The company announced and stated that it will begin shipping its natural zeolite to several medical marijuana growers in Canada and the United States. Currently, the Canadian Zeolite team is proceeding with developing zeoponics and zeoponic substrates specifically for use in the growing of medical marijuana. Zeoponics allows the plant to absorb the nutrients as it needs them, which improves the plant quality, produces higher yields and shortens production cycles. In addition, natural zeolite aids in control of mould and moisture issues in standard plant growing operations.

Canadian Zeolite Corp. CEO, Ray Paquette, said in a statement "with the explosive growth of the medical marijuana industry, Canadian Zeolite is well-positioned to become a leading supplier of natural zeolite to this expanding market as well as becoming an innovator of new products to compliment the growing process."

General Cannabis Corp. (OTCQB: CANN) is the resource for top quality service suppliers available to the regulated Cannabis Industry. General Cannabis is a partner to the production and marketing side of the cannabis business. CANN does this through a mixture of operating divisions such as real estate, consulting, security, financing and the distribution of vital infrastructure products to cultivate facilities and dispensaries.

American Cannabis Company Inc. (OTCQB: AMMJ) has secured a new contract with a Canadian firm to create a cannabis Licensed Producer facility within the Atlantic Provinces. Engagements connected to this project will start with the cultivation of an alternative crop, and then a shift to cannabis production as soon as operational licensing is secured. Future plans call for the creation of green houses and further indoor development.

Terra Tech Corp. (OTCQX: TRTC) subsidiary IVXX™, hand selects and harvests the finest-grade cannabis under the safest and most beneficial conditions, free of toxic pesticides, harmful molds and chemical residues. Its products are carefully produced, rigorously tested and certified to the highest standards of potency and purity. Currently, the company's hand selected strains are the I-Hybrid and S-Hybrid. IVXX offers pure concentrates ranging from Shatter, Wax to Oil, which are all produced in its advanced extraction labs, along with custom rolled joints.

GrowBlox Sciences Inc. (OTCQB: GBLX) recently announced the filing of the first of several patent applications for life science inventions by its wholly-owned subsidiary, Growblox Life Sciences, LLC.  The current provisional patent application covers complex-cannabinoid-containing mixtures capable of enhancing dopamine secretion and protect neurons from the mitochondrial-induced free radical damage that occurs during disease progression in the brains of patients with Parkinson's disease, Alzheimer's disease, Lewy Body Dementia, and Huntington's disease, among others.

Subscribe Now! Watch us report from NYSE

For "The Latest Buzz in Financial News", SIGN UP & Visit:

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. expects to be compensated four thousand dollars for financial news dissemination and pr services for canadian zeolite corp. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information:

Media Contact: , +1-877-601-1879




Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store